July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Michael Dickinson: COALITION Study is online JCO ASCO – An IIT and the 1st Bispecific Glofitamab in High-Risk DLBCL
Jun 20, 2025, 15:33

Michael Dickinson: COALITION Study is online JCO ASCO – An IIT and the 1st Bispecific Glofitamab in High-Risk DLBCL

Michael Dickinson, Haematologist, Professor at the University of Melbourne, shared a post on X:

“COALITION is online JCO ASCO – an IIT and the FIRST bispecific glofitamab First Line trial to target very high risk DLBCL lymphoma in younger patients. Great work from Adrian Minson and thanks to investigators and teams across Oz. 18ICML and thanks to Peter Mac Cancer Centre.
Some interesting observations about pet scans in the context of front line bispecific and also some mrd data that will interest many.

Title: Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study

Authors: Adrian Minson, Emma Verner, Pratyush Giri, Jason Butler, Wojt Janowski, Chan Y. Cheah, Sumita Ratnasingam, Shu Min Wong, Matthew Ku, Mark Hertzberg, Kirsten Herbert, Nada Hamad, Costas K. Yannakou, Fiona Swain, Paul Neeson, Thiago M. Steiner, Javad Saghebi, Piers Blombery, Sally M. Hunter, Molly Robertson, Lei Shong Lau, Rory Bennett, Sean Harrop, Jing Xie, John F. Seymour

Read Full Article.

COALITION

More posts featuring Michael Dickinson on OncoDaily.